Global Mycoplasma Testing Industry Growth, Share, Value Forecast Reports
Posted by rohan on September 22nd, 2017
The Global mycoplasma testing market was worth USD 465.1 Million in 2016 and is estimated to be growing at a CAGR of 12.7%, to reach USD 845.7 Million by 2021. Mycoplasma is a type of bacteria and they do not possess a cell wall or cell membrane. Since most of the common antibiotics are designed to target cell wall synthesis; they do not work against Mycoplasma. They are one of the smallest bacteria and cannot be observed using a normal microscope.
Browse Full Report @ http://www.marketdataforecast.com/market-reports/mycoplasma-testing-market-3662/
Mycoplasmas are more frequently found as contaminants in cell culture research laboratories. The contamination can either be carried inside by an individual or from the materials brought from outside the laboratory. In order to prevent further contamination, mycoplasma testing is recommended for all cell culturists. There are many mycoplasma tests available in the market. Mycoplasma infections cannot be allowed to grow in cell culture as they tend to bring changes in chromosomes and affect the cell growth.
Download Free Sample Report @ http://www.marketdataforecast.com/market-reports/mycoplasma-testing-market-3662/request-sample
As the investments in research and development are increasing in the field of life sciences, the increase in demand for mycoplasma testing products is predicted in the forecast period. With the increase in healthcare expenditure all over the world, pharmaceutical and biotechnology industries are heavily investing in R&D activities. Government Initiatives are funding research on drug discovery and development. All these factors are responsible for driving the growth of mycoplasma testing market. However, strict government regulations and high costs of mycoplasma testing are the major restraining factors for the market.
On the basis of geography, the market for mycoplasma testing is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. North America dominates the mycoplasma testing market and Europe is not far behind. Asia-Pacific region is projected to have the fastest growth rate due to the huge opportunities available in countries like China, India and Japan. Increasing pharma and biotech companies and their investments in R&D and various government initiatives are expected to drive the market growth.
The key players in the mycoplasma testing market include Thermo Fisher Scientific Inc., Minerva Biolabs GmbH, Charles River Laboratories International, Inc., Gibraltar Laboratories, Sartorius AG, Lonza Group Ltd., Merck KGaA, Roche Diagnostics, SGS S.A., American Type Culture Collection, InvivoGen, PromoCell GmbH, Biological Industries Israel Beit Haemek Ltd., and WuXi AppTec.
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Like it? Share it!
About the Authorrohan
Joined: September 20th, 2017
Articles Posted: 1,346
More by this author